Stock UniverseDerived research view · source repositories remain read-only

Lexicon Pharmaceuticals, Inc. (LXRX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Watch
Selection Score
30.91
Global Rank
1827
Market Cap
627.81M
Latest Close
1.91
RS Composite
18.52% · G#488

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
19.37%
3M
11.70%
6M
36.43%
1Y
189.39%
3Y
-42.12%
5Y
-56.49%
10Y
-86.56%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.73M · 30-day average: 2.75M · Max drawdown over stored range: -98.50%

Research Snapshot

Relative Strength vs SPX

RS Composite18.52%
20D RS13.05%
60D RS2.07%
120D RS37.70%
Global RS Rank488 · 85.45% percentile
Watch+Speculative RS Rank290 · 86.17% percentile
Group ScopeWatch+Speculative
Primary RS Rank73 · 84.06% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank247 / 701
Primary Percentile64.91
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-0769.64Mn/a-24.23M-26.09M-0.07-109.37Mn/an/a373Mn/a-34.79%-37.46%-1.57%n/a170.66M49.68M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-0.07-27.3x$0.1910.2xn/an/a$-0.29-6.5x

Shares Diluted: 373M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue23.9950.2980.1391.20431.08149.803
Revenue Growth (YoY)-92.55%-98.758%-53.356%766.187%2481.478%60.236%
Gross Profit-129.055-54.748-52.377-57.768-52.915
Operating Income-173.285-87.09-100.46-170.31-184.817
Free Cash Flow-143.056-88.238-90.177-162.367-179.811-67.851
Free Cash Flow Per Share-1.291-0.606-0.544-0.734-0.562-0.18689006839221825
EPS (Diluted) GAAP-0.52845-0.602518-0.615109-0.800972-0.626198
EPS Growth
EPS Non-GAAP
Gross Margin9000%9000%9000%9000%-170.249%99.4498%
Operating Margin-722.171%-29224.832%-72273.381%-14145.349%-594.63%-98.2089%
Profit Margin-244.109%-29448.993%-73341.007%-14710.88%-644.777%-101.0803%
Free Cash Flow Margin-596.191%-29610.067%-64875.54%-13485.631%-578.524%-136.2388%
Shares Outstanding (Diluted)110.841145.652165.733221.13320.031363.053
Shares Change (YoY)-5.059%31.406%13.787%33.425%44.725%13.443%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-0721.10Mn/a-996.00K-4.72%-1.04M-4.94%-0.07400.24M170.66M49.68Mprocessed
2025 Q42026-03-055.49Mn/a-14.78M-2.69%-15.53M-2.83%-0.04363.43M96.23M49.41Mprocessed
2025 Q32025-11-0614.18Mn/a-12.19M-85.93%-12.77M-90.04%-0.04363.40M115.95M56.51Mprocessed
2025 Q22025-08-0628.87Mn/a3.74M12.94%3.25M11.27%0.01363.57M139.01M56.11Mprocessed
2025 Q12025-05-141.26Mn/a-25.68M-20.35%-25.30M-20.04%-0.07362.07M194.84M58.64Mprocessed
2024 Q42025-03-071.55Mn/a-32.74M-21.12%-33.77M-21.78%-0.09361.80M237.96M100.30Mprocessed
2024 Q32024-11-131.74Mn/a-63.69M-36.58%-64.81M-37.23%-0.18361.49M258.37M99.89Mprocessed
2024 Q22024-08-021.62Mn/a-55.35M-34.23%-53.43M-33.04%-0.17310.84M309.96M99.50Mprocessed
2024 Q12024-05-021.09Mn/a-45.33M-41.48%-48.40M-44.28%-0.20245.39M355.60M99.87Mprocessed
2023 Q42024-03-25672.00Kn/a-46.74M-69.55%-49.76M-74.04%-0.20245.18M170.03M99.51Mprocessed
2023 Q32023-11-08148.00Kn/a-49.63M-335.34%-50.52M-341.39%-0.21244.93M218.43M99.27Mprocessed
2023 Q22023-08-04291.00Kn/a-44.24M-152.03%-44.90M-154.31%n/an/a256.74M98.77Mprocessed
2023 Q12023-05-04n/an/a-31.14Mn/a-31.93Mn/an/an/a105.94M48.84Mprocessed
2022 Q32022-11-09n/an/a-23.09Mn/a-23.39Mn/an/an/a136.20M23.78Mprocessed
2022 Q22022-08-03n/an/a-24.01Mn/a-24.59Mn/an/an/a61.97M23.63Mprocessed
2022 Q12022-05-05n/an/a-23.38Mn/a-23.48Mn/an/an/a86.50M23.48Mprocessed
2021 Q32021-11-0923.00Kn/a-22.96M-998.35%-23.12M-1005.30%-0.16145.82M120.92Mn/aprocessed
2021 Q22021-08-06234.00Kn/a-17.96M-76.75%-18.07M-77.21%n/an/a118.50Mn/aprocessed
2021 Q12021-05-0627.00Kn/a-20.84M-771.81%-20.96M-776.22%n/an/a141.36Mn/aprocessed
2020 Q32020-10-306.63Mn/a86.67M13.07%82.60M12.45%0.71117.55M111.45M11.63Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.